Clinical Trial

Randomized Controlled Clinical Study on the Reduction of Tumor Marker Levels in Breast Cancer Patients by Huaier Granules

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated September 8, 2025 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is a prospective, multicenter, randomized controlled clinical trial designed to evaluate the rate of reduction of tumor markers to normal levels in breast cancer patients treated with Huaier granules compared to the control group.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-05-12; most recent amendment 2025-09-01.
Status change: Recruiting → Not Yet Recruiting 2025-09-01
Status change: Not Yet Recruiting → Recruiting 2023-08-29
Trial Details
NCT Number NCT05871437
Lead Sponsor Fudan University
Collaborators: LinkDoc Technology (Beijing) Co. Ltd., Huazhong University of Science and Technology
Conditions Breast Cancer
Enrollment 232 participants
Start Date 2025-09
Primary Completion 2026-01 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-08